Summary
Boston Scientific Corporation (BSX) filed an 8-K on February 4, 2016, primarily to furnish a press release announcing their financial results for the fourth quarter and full year ended December 31, 2015. This filing serves as a crucial update for investors, providing the latest performance metrics and financial condition of the company. While the 8-K itself doesn't contain detailed financial statements, it directs stakeholders to the accompanying press release (Exhibit 99.1) for the specific figures and commentary on their operational performance. Investors should pay close attention to the press release referenced in this filing to understand BSX's revenue growth, profitability trends, and any forward-looking statements or guidance provided for the upcoming periods. The furnished information is essential for assessing the company's trajectory and making informed investment decisions. It's important to note that the information provided in this Item 2.02 and Exhibit 99.1 is furnished and not deemed 'filed' under Section 18 of the Exchange Act.
Key Highlights
- 1Boston Scientific announced its Q4 and full-year 2015 financial results via press release on February 4, 2016.
- 2The 8-K filing on February 4, 2016, is primarily to furnish the press release containing these financial results.
- 3Exhibit 99.1 contains the official press release with detailed financial performance for the periods ending December 31, 2015.
- 4Investors are directed to the furnished press release for operational and financial condition updates.
- 5The information is furnished and not deemed 'filed' for the purposes of Section 18 of the Exchange Act.
- 6This filing allows investors to access the most recent performance data shortly after the period end.